FindTrial
Sign In

A study of the safety and sustainability of pain therapy with conditioned medium

A study of the safety and sustainability of pain therapy with human adipose-derived mesenchymal stem cell conditioned medium

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1030220247
Enrollment
Unknown
Registered
2022-08-05
Start date
2022-06-03
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain

Interventions

None listed

Sponsors

Suzuki Hidehiko
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with chronic pain 2. Patients who did not have a satisfactory pain relief effect with standard treatment 3. Patients who do not wish to be treated with the drugs used in standard of care 4. Patients over 18 years old 5. Patients with normal consent ability 6. Patients who can obtain their free will consent in writing 7. Patients whose doctor recognizes the need for treatment

Exclusion criteria

Exclusion criteria: 1. Patients with a history or suspicion of malignant tumor or dementia 2. Drug and stimulant users 3. Patients with no pain other than psychogenic pain 4. Patients who do not understand and agree with this treatment 5. Pregnant 6. Patients that the doctor in charge deems inappropriate

Design outcomes

Primary

MeasureTime frame
Subjective symptoms 1. Effect of pain on daily life 2. Pattern of pain 3. Pain intensity (Numerical Rating Scale; NRS) 4. Pain area 5. Characteristics of pain—

Contacts

Public ContactHidehiko Suzuki

Suzuki Clinic Orthopaedics River City

hidehikosuzuki@mac.com+81-3-3534-5678

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026